6-12 months behind FDA: EMA decision for the EU market, following the standard lag
Similar cardiovascular outcomes in patients with diabetes and established or high risk for cor- onary vascular disease treated with dulaglutide with and without baseline metformin
In the SURMOUNT-5 trial, which directly compared the two medications, Mounjaro 15 mg produced 20.2% weight loss, while Wegovy 2.4 mg produced 13.7% over 72 weeks
Once your provider finalizes your plan, your kit typically arrives within 710 business days, packaged with cold-chain protection where required
We tailor your dosage and program based on your specific needs, goals, and how your body responds
There are no clear estimates of how big this market is, but the information experts do have suggests it is sizable